SABS
SAB Biotherapeutics, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
SAB Biotherapeutics (SABS) Stock: Buy, Sell, or Hold?
$3.11
+0.04 (+1.30%)
â˛
5d:
-2.2%
30d:
+16.04%
90d:
-17.07%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (42%)
Quality Score
38/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$2.72 â $3.17
Position: SLIGHTLY HIGH
Forward P/E & Valuation
-3.3x
Next 12M consensus est.
Wall Street Target
$11.64
+274.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.91 / $3.40
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: SABS is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When SABS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SABS is currently trading at $3.11, which is considered slightly high relative to its 30-day fair value range of $2.72 to $3.17.
Technical Outlook: Technically, SABS is in a strong downtrend. Immediate support is located at $2.91, while resistance sits at $3.40.
Market Sentiment: SABS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.64 (+274.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SABS is in a strong downtrend. Immediate support is located at $2.91, while resistance sits at $3.40.
Market Sentiment: SABS scores 38/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.64 (+274.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$2.72 -
$3.17
Company Quality Score
38/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
42.1%
Trading Range & Key Levels
30-Day Trading Range
$2.72 -
$3.17
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$2.91
Resistance Level
$3.40
Current Trend
Strong Downtrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (38/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 274.2% below Wall St target ($11.64)
- WARNING: Composite score 38/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.30
Wall Street Target
$11.64
(+274.2%)
Revenue Growth (YoY)
-62.4%
Earnings Growth (YoY)
-60.0%
Share SABS Analysis
Share this live SABS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SABS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 29, 2026
Daily AI digest
AI Retail Discussion Summary:
A bullish StockTwits user shared a link to an educational video on $SABS, expressing optimism about the stock.
Key Retail Themes:
educational content
positive outlook
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:10 AM ET
Data refreshes hourly during market hours. Next update: 8:10 AM
Data refreshes hourly during market hours. Next update: 8:10 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SABS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron PharmaceuticalâĻ |
BUY
28 analysts |
$978 | 35 SELL |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 31 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 35 SELL |
|
BNTX
BioNTech SE |
BUY
21 analysts |
$114 | 62 BUY |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SABS Research Pages
